Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 51Rectal Neoplasms 27Colonic Neoplasms 16Stomach Neoplasms 14Carcinoma, Hepatocellular 14Neoplasm Metastasis 9Adenocarcinoma Of Esophagus 7Esophageal Neoplasms 6Neoplasms 5Cholangiocarcinoma 5Recurrence 3Pancreatic Neoplasms 3Esophageal Squamous Cell Carcinoma 3Digestive System Neoplasms 3Adenocarcinoma 3Ovarian Neoplasms 2Liver Neoplasms 2Intestinal Neoplasms 2Gastrointestinal Neoplasms 2Gastrointestinal Diseases 2Cirrhosis, Familial, with Pulmonary Hypertension 2Biliary Tract Neoplasms 2Peritoneal Neoplasms 1Pancreatic Adenocarcinoma 1Operable T2-3N+M0 Rectal Cancer (Stage III) 1Neurotoxicity Syndromes 1Metastatic Colorectal Adenocarcinoma 1Locally Advanced Pancreatic Carcinoma(LAPC) 1Locally Advanced Colorectal Carcinoma 1Intestinal Diseases 1

Interventions

lenvatinib 3Gemcitabine 3tislelizumab 2pembrolizumab 2Cisplatin 2toripalimab 1titanium silicide 1theasinensin A 1surufatinib 1sitravatinib 1sintilimab 1durvalumab 1S 1 (combination) 1Nivolumab 1Folfox protocol 1Fluorouracil 1Cryosurgery 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Advanced Biliary Tract Cancer × Folfox protocol × Clear all
NCT04217954 2023-06-23

HAIC With Oxaliplatin, 5-FU and Bevacizumab Plus Intravenous Toripalimab for Advanced BTC

Peking University

Phase 2 Completed
32 enrolled
Gastrointestinal

Advanced Biliary Tract Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡